AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAY 5 - (NewsRx.com & NewsRx.net) -- Scientists have characterized a fusion anti-caries DNA vaccine against PAc and glucosyltransferase I of Streptococcus mutans.
"Glucosyltransferases (GTFs) and A cell-surface protein (PAc) are two important virulence of the cariogenic organism Streptococcus mutans. They may mediate sucrose-in dependent or sucrose-dependent attachment of Streptococcus mutans to tooth surfaces, respectively. Thus, inhibiting both virulence factors is predicted to provide better protection against caries than inhibiting a single factor," researchers in China report.
"To develop a highly efficient vaccine against caries, we constructed a fusion DNA vaccine, pGLUA-P, by cloning the GLU region of GTF into a DNA vaccine, pCIA-P, which encodes two highly conservative regions of Pac," stated J. H. Guo and colleagues at Wuhan University. "In this report, we provide evidence that fewer caries lesions were observed in rats following subcutaneous injection of pGLUA-P, compared with pCIA-P, near the submandibular gland. Our findings suggest that a multigenic DNA vaccine may be more ...